MRK

SELL

Merck & Company, Inc.

Healthcare · Rank #379 · Analyzed Oct 18, 2026

$145.95

Current Price

$165.74

Intrinsic Value

+13.6%

Upside/Downside

1.5/10

Score

1.5/5

Quality

Analysis Summary

Valuation Consensus1/2 methods agree

Quality Score1.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueUndervalued by 13.6%

Fair Value Range

Low$87.32

Base (IV)$165.74

High$210.02

Entry Points

Conservative$61.12

Moderate$87.32

Aggressive$116.02

Quality & Moat Breakdown

Return on Equity7.0% → 0/1.0

Debt LevelD/E 128 → 0/1.0

Revenue QualityGrowth 7.8%, margin Δ-25.5% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins4.8% → 0.5/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.